Liam M. Murray

Learn More
Preclinical evidence suggests that aspirin may inhibit lung cancer progression. In a large cohort of lung cancer patients, we investigated whether low-dose aspirin use was associated with a reduction in the risk of lung cancer-specific mortality. We identified lung cancer patients from English cancer registries diagnosed between 1998 to 2009 from the(More)
  • 1